Registry of People with Long COVID in Navarre
Records long-term symptoms and complications in people with long COVID in Navarre.
Plain-language title generated from the registry record
Registry title: Persistent COVID-19 Registry in Navarre.
Key facts
- Where
- Pamplona, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for people who had confirmed SARS-CoV-2 infection and still have symptoms more than 3 months later (long COVID).
- Sex
- All sexes can join.
- Disease stage
- Symptoms that have lasted more than 3 months after confirmed SARS-CoV-2 infection.
- Biomarker or test result
- Confirmed past SARS-CoV-2 infection.
Main reasons for not taking part
- Symptoms that already existed before the acute SARS-CoV-2 infection
Read by machine on 12 November 2026.
Where in Spain
- Hospital Universitario de NavarraPamplona, SpainContact: Patricia Fanlo Mateo., MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundacion Miguel Servet
- Trial code
- NCT07417176
- Record updated
- 20 February 2026
- Original description
The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre.Read full original descriptionShow less
Persistent COVID-19 Registry in Navarre. (Persicov-19)
The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre.
Sociodemographic variables such as age, sex, ethnicity, smoking history, and comorbidities will be collected, as well as clinical and disease management variables such as persistent COVID-19 symptoms at 3 months, all with the aim of characterizing patients with long COVID.
All patient data will be collected in a single visit.
Inclusion: History of confirmed SARS-CoV-2 infection; Presentation of symptoms that have persisted for more than 3 months after SARS-CoV-2 infection; The patient reports any of the symptoms listed in the clinical assessment questionnaire or checklist.
Exclusion: The symptom(s) referred to already existed prior to acute SARS-CoV-2 infection.